Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-019194)

Filing Details

Accession Number:: 0000899243-17-019194
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-07-27 17:11:17
Reporting Period:: 2017-07-25

Filing Date:: 2017-07-27
Accepted Time:: 2017-07-27 17:11:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1552451	Myokardia Inc	MYOK	Pharmaceutical Preparations (2834)	455500552

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654909	Jake Bauer	C/O Myokardia, Inc. 333 Allerton Avenue South San Francisco CA 94080	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-07-25	4,333	$15.02	80,545	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $15.00 to $15.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.